128 related articles for article (PubMed ID: 12434403)
1. Preliminary pharmacokinetic study of different preparations of acyclovir with beta-cyclodextrin.
Luengo J; Aránguiz T; Sepúlveda J; Hernández L; Von Plessing C
J Pharm Sci; 2002 Dec; 91(12):2593-8. PubMed ID: 12434403
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
5. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
[TBL] [Abstract][Full Text] [Related]
6. Enhanced bioavailability of process-induced fast-dissolving ibuprofen cogranulated with beta-cyclodextrin.
Ghorab MK; Adeyeye MC
J Pharm Sci; 2003 Aug; 92(8):1690-7. PubMed ID: 12884255
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
[TBL] [Abstract][Full Text] [Related]
8. β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.
Malik NS; Ahmad M; Alqahtani MS; Mahmood A; Barkat K; Khan MT; Tulain UR; Rashid A
Drug Deliv; 2021 Dec; 28(1):1093-1108. PubMed ID: 34114907
[TBL] [Abstract][Full Text] [Related]
9. Enhanced bioavailability of soy isoflavones by complexation with beta-cyclodextrin in rats.
Lee SH; Kim YH; Yu HJ; Cho NS; Kim TH; Kim DC; Chung CB; Hwang YI; Kim KH
Biosci Biotechnol Biochem; 2007 Dec; 71(12):2927-33. PubMed ID: 18071265
[TBL] [Abstract][Full Text] [Related]
10. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration.
Lin HS; Chan SY; Low KS; Shoon ML; Ho PC
J Pharm Sci; 2000 Feb; 89(2):260-7. PubMed ID: 10688755
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
12. [A preliminary study of pharmacokinetics of evodiamine hydroxypropyl-β-cyclodextrin inclusion complex].
Zhang X; Liu HM; Lei TT; Feng J; Zhang JQ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):548-51. PubMed ID: 27113185
[TBL] [Abstract][Full Text] [Related]
13. Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat.
Westerberg G; Wiklund L
J Pharm Sci; 2005 Jan; 94(1):114-9. PubMed ID: 15761935
[TBL] [Abstract][Full Text] [Related]
14. Availability of phenindione-beta-cyclodextrin inclusion complex.
Tous SS; el-Sayed AM; el-Harras SA; Jun HW
Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Little JL; Malcolm MO; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Mar; 96(3):644-60. PubMed ID: 17083091
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics of beta-cyclodextrin derivative-based formulations of acitretin in Sprague-Dawley rats.
Liu X; Lin HS; Chan SY; Ho PC
J Pharm Sci; 2004 Apr; 93(4):805-15. PubMed ID: 14999719
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats.
Ventura P; Panini R; Montosi G; Garuti C; Vandelli M; Brunetti G; Tauschel H; Pietrangelo A; Salvioli G
Pharmacology; 2001 Feb; 62(2):107-12. PubMed ID: 11174081
[TBL] [Abstract][Full Text] [Related]
19. Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.
Nakate T; Yoshida H; Ohike A; Tokunaga Y; Ibuki R; Kawashima Y
Eur J Pharm Biopharm; 2003 Mar; 55(2):147-54. PubMed ID: 12637090
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
